Related Experiment Videos
The clinical spectrum of giant cell arteritis
J C Mertens1, J T van Dissel, R E Kibbelaar
1Department of Rheumatology, University Hospital Leiden, The Netherlands.
Insights
Giant cell arteritis (GCA) can affect various blood vessels, presenting diverse symptoms. Immunosuppressive drugs effectively halted disease progression in three patients, highlighting GCA
Area of Science:
- Rheumatology
- Vascular Medicine
- Immunology
Background:
- Giant cell arteritis (GCA) is a vasculitis primarily affecting large and medium-sized arteries.
- Understanding the full spectrum of GCA is crucial for diagnosis and management.
Observation:
- Three patients presented with GCA involving multiple medium and large vessels, including the temporal artery and aorta.
- Symptoms included malaise, myalgias, and ischemia due to reduced blood flow.
- Temporal arteritis and Takayasu's arteritis may represent distinct subsets within the GCA spectrum.
Findings:
- Immunosuppressive therapy successfully halted disease progression in all observed GCA cases.
- GCA exhibits a broad clinical and pathological spectrum beyond cranial involvement.
Implications:
- This case series broadens the recognized disease spectrum of giant cell arteritis.
- Highlights the importance of considering GCA in patients with unexplained systemic symptoms and large vessel involvement.
- Suggests immunosuppression as an effective treatment strategy for diverse GCA presentations.
Abstract:
Three patients are described with giant cell arteritis (GCA) of multiple medium sized and large blood vessels including the temporal artery and the aorta. The patients presented with malaise, myalgias and different symptoms due to decreased local blood flow. Progression of the disease could be blocked with immunosuppressive drugs in all 3 patients. With this report we want to emphasize that GCA is associated with a wide ranging disease spectrum in which temporal arteritis and Takayasu's arteritis represent two subsets.